Santen
Ryo Kishimoto is a seasoned business development executive with extensive experience in the pharmaceutical and healthcare industries. Currently serving as the Global Head of Business Development at Santen since June 2025, Kishimoto is responsible for driving growth through global and regional acquisitions, licensing, and partnerships. Prior to this role, Kishimoto held various leadership positions at Sandoz, including Head of Business Development for the Asia Cluster and Strategic BD&L Projects Lead, where efforts focused on high-value growth through in-licensing and distribution. Additional experience includes leadership roles at Novartis, DKSH, and Pfizer, with a track record in managing multi-market operations, strategic planning, and product launch initiatives. Kishimoto began professional career at Santen and has a B.A. in International Business from Kansai University.
This person is not in any teams
This person is not in any offices
Santen
7 followers
SANTEN PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and sales of pharmaceutical products. The Company has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The Company engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The Company operates in Japan, Europe, Asia, North America markets.